Introduction {#S0001}
============

Phyllodes tumor is a very rare tumor of the breast, incidence being between 0.3% and 0.9% of all breast tumors.[@CIT0001] They are most commonly found in women aged between 40 and 50 years.[@CIT0002] The World Health Organization (WHO) has published guidelines classifying this tumor into benign, borderline or malignant according to the histological features such as stromal cellularity, stromal overgrowth, stromal atypia, mitoses/high power field and tumor margin. The most common grade of phyllodes tumor is benign, benign tumor occurrence being between 60% and 75% of the cases.[@CIT0003] In the past, several literatures recommended that the standard treatment for phyllodes tumor is surgery to remove tumor with a free margin of at least 1 cm to reduce local recurrent.[@CIT0004]--[@CIT0006]

In this paper, we aimed to investigate patient characteristics, characteristic imaging findings, histopathological diagnostics, surgical treatment and therapeutic outcome of phyllodes tumor patients at Chiang Mai University Hospital over a 10-year period. We also investigated factors related to recurrence.

Materials and methods {#S0002}
=====================

This is a retrospective review of patients who were diagnosed with a phyllodes tumor and underwent surgical management. Data were collected from electronic medical records from 1 January 2006 to 31 December 2015 in the Head, Neck and Breast Unit, Department of Surgery, Chiang Mai University Hospital.

Patients data were collected from physical examination. These included age, menopausal status, location of tumor and tumor size from physical examination. Mammography and ultrasonography images were used to evaluate each mass. Details pertinent to tumor size, shape and margin were collected. Three operation procedures for surgical management included wide excision, wide excision followed by mastectomy if the margin was inadequate and mastectomy. The final pathology diagnoses following the operation were divided into benign, borderline and malignant phyllodes tumors in accordance with the WHO criteria. All patients were followed up at least 3 years after operation to check for recurrence. Any recurrence was reported as local (new tumor was found in ipsilateral breast) or distant metastatic recurrence.

Statistical analysis {#S0003}
====================

Categorical data are presented as frequency and percentage. Fisher's exact test was used as a means of comparing the categorical variables. Continuous data are presented as mean and standard deviation. Differences between the three groups of phyllodes tumor were assessed using a one-way analysis of variance (ANOVA) test. Multivariable Cox's proportional hazard model with a step backward elimination method was used to identify the prognostic factors of recurrent phyllodes tumor. The overall survival curves were estimated using the Kaplan--Meier method. All statistical analyses were performed using STATA program version 11.0 (Serial number: 40110561832)

Results {#S0004}
=======

Patient characteristics {#S0004-S2001}
-----------------------

The study was submitted to the ethics review board of the Faculty of Medicine Chiang Mai University and approved it. Our retrospective study was scrutinized without requiring consent from patients, because this study was low risk and we collected data as anonymous.

In this study, 188 patients with phyllodes tumor who had been diagnosed and treated in our hospital were included. All patients presented at the hospital with a palpable breast mass. The average age was 35.6 years old (youngest 13 and oldest 77). One hundred and sixty-five women were pre-menopausal and 23 post-menopausal. The phyllodes tumor was in the right breast in 113 cases and the left breast in 75 cases. The mass was located in the upper outer quadrant in 78 cases, the upper inner quadrant in 48 cases, the lower outer quadrant in 19 cases, the lower inner quadrant in 11 cases and centrally in 32 cases ([Table 1](#T0001){ref-type="table"}). Table 1Patient and tumor characteristicsParametersTypes of phyllodes tumors*P*-valueBenign N=118Borderline N=33Malignant N=37**Age** Mean (SD)31.9 (12.3)40.4 (14.9)48.1 (10.8)\<0.001 Min--Max13--7017--6421--77**Age 45** \<4597 (82.2)21 (63.6)13 (35.1)\<0.001 ≥4521 (17.8)12 (36.4)24 (64.9)**Menopause, n (%)** Yes4 (3.4)8 (24.2)11 (29.7)\<0.001 No114 (96.6)25 (75.8)26 (70.3)**Site, n (%)** Right66 (55.9)19 (57.6)19 (51.4)0.330 Left42 (35.6)12 (36.4)18 (48.7) Bilateral10 (8.5)2 (6.1)0**Quadrant, n (%)** UOQ & UIQ81 (68.6)15 (45.5)20 (54.1)0.042 Central12 (10.2)9 (27.3)10 (27.0) LIQ & LOQ16 (13.6)7 (21.2)6 (16.22) Multiple9 (7.6)2 (6.1)1 (2.7)**Radiological, n (%)** Ultrasound (US)56 (47.5)13 (39.4)5 (13.5)0.001 US and mammogram41 (34.8)17 (51.5)25 (67.6) Not performed21 (17.8)3 (9.1)7 (18.9)**Mass shape, n (%)** Lobulated60 (50.9)21 (63.6)24 (64.9)0.555 Oval21 (17.8)7 (21.2)2 (5.4) Irregular4 (3.4)01 (2.7) Round6 (5.1)1 (3.0)1 (2.7) Multiple4 (3.4)02 (5.4) Unknown23 (19.5)4 (12.1)7 (18.9)**Mass margin, n (%)** Well-defined93 (78.8)27 (81.8)29 (78.4)0.524 Ill-defined2 (1.7)2 (6.1)1 (2.7) Not performed23 (19.5)4 (12.1)7 (18.9)**Operation type, n (%)** Wide excision116 (98.2)23 (69.7)8 (21.6)\<0.001 Mastectomy1 (0.9)6 (18.2)13 (35.2) Excision followed by mastectomy1 (0.9)4 (12.1)16 (43.2)**Surgical margin** Free\>1 cm65 (55.1)11 (34.4)8 (21.6)0.002 Positive53 (44.9)21 (65.6)29 (78.4)**Tumor size, n (%)** ≤6 cm106 (89.8)20 (60.6)21 (56.8)\<0.001 \>6 cm12 (10.2)13 (39.4)16 (43.2) Mean (SD)3.5 (2.1)6.6 (4.5)8.2 (5.7)**Radiation, n (%)** Yes0 (0)5 (15.2)19 (51.4)0.001 No118 (100)28 (84.8)18 (48.6)**Recurrence** Yes5 (4.2)2 (6.1)4 (10.8)0.356 No113 (95.8)31 (93.9)33 (89.2)[^1]

Imaging characteristics {#S0004-S2002}
-----------------------

Mammogram and ultrasonography were used to evaluate 182 cases. Ultrasonography alone was used in 74 cases and no imaging took place in 31 cases ([Table 1](#T0001){ref-type="table"}).

Tumor consistency was divided into two main groups: solid 139 cases and mixed solid-cystic 15 cases.

Tumor shapes were: lobulated 112 cases ([Figure 1](#F0001){ref-type="fig"}); oval 37 cases; round 8 cases and irregular in 5 cases.

The groupings of the margin border of the tumor were: well defined 149 cases and ill defined 5 cases. Figure 1Mammogram and ultrasonography showed large lobulated patient who was diagnosed phyllodes tumor.

Types of operation {#S0004-S2003}
------------------

In benign phyllodes tumor group, wide excision was performed in 116 cases, mastectomy in 1 case and excision followed by mastectomy 1 case. In borderline phyllodes tumor group, wide excision was performed in 23 cases, mastectomy in 6 cases and excision followed by mastectomy 4 cases. In malignant phyllodes tumor group, wide excision was performed in 8 cases, mastectomy in 13 cases (modified radical mastectomy in 2 cases; 1 patient was negative for lymph node metastasis and 1 patient had metastatic lymph nodes 1 in 13 nodes, indication for 2 patients was axillary lymph nodes palpable without preoperative proven metastasis) and excision followed by mastectomy 16 cases. A surgical free margin (at least 1 cm from tumor) was recorded in 84 cases. A surgical positive margin after the first operation was found in 53 cases in benign, 21 cases in borderline and 29 cases in malignant phyllodes tumor ([Table 1](#T0001){ref-type="table"}). In case of positive margin, 21 cases divided into 1 case of benign, 4 cases of borderline and 16 cases were malignant undergone re-operation and a free margin was finally achieved. Location of the tumor did not affect the free surgical margin ([Table 2](#T0002){ref-type="table"}). In univariate analysis, we found that the type of operation and margin status did not affect recurrence. ([Table 3](#T0003){ref-type="table"}) Table 2Relation of the location of the tumor (cm)QuadrantPositiveFree margin*P*-valueUOQ24 (33.80)47 (66.20)0.370Central9 (29.03)22 (70.97)UIQ22 (47.73)23 (52.27)LIQ6 (54.55)5 (45.45)LOQ7 (38.89)11 (61.11)Multiple5 (25.00)9 (75.00)Total71 (37.43)117 (62.57) Table 3Prognostic factors of disease recurrence analyzed by univariable and multivariable Cox proportional hazard modelParametersCrude HR (95% CI)*P*-valueAdjusted HR (95% CI)*P*-value**Age** \>451 (reference)--1 (reference) ≤450.2 (0.03--1.7)0.1410.1 (0.004--0.5)0.015**Pathology** Benign1 (reference)--1 (reference) Borderline1.2 (0.2--6.4)0.7992.3 (0.3--15.5)0.385 Malignant2.4 (0.6--8.9)0.19210.6 (1.5--77.4)0.020**Surgical margin** Free margin1 (reference)------ Positive margin1.2 (0.4--4.1)0.738**Operation type** Wide excision1 (reference)---- Mastectomy Excision followed by mastectomy0.7 (1.0--5.7)0.761 No1 (reference)0.449 Yes0.4 (0.1--3.8)**Tumor size** ≤61 (reference)--1 (reference)-- \>64.2 (1.3--13.9)0.0174.4 (1.2--16.7)0.029

Final pathology {#S0004-S2004}
---------------

Out of the 188 cases of phyllodes tumors, 118 cases were benign (62%), 33 (18%) were borderline and 37 cases (20%) were malignant ([Table 1](#T0001){ref-type="table"}). If the size of the tumor is more than 6 cm, it should be suspected for malignant phyllodes tumor ([Table 1](#T0001){ref-type="table"}).

Adjuvant treatment {#S0004-S2005}
------------------

In our hospital, we considered radiotherapy as an adjunctive treatment for malignant phyllodes tumors and some borderline phyllodes tumors. Twenty-three cases received adjuvant radiotherapy: 5 of these were borderline and 19 were malignant. No systemic therapy was given in any patient.

Follow up and recurrence {#S0004-S2006}
------------------------

All patients were followed up with physical examination at outpatient department (OPD) every 3 months in first year, every 6 months in second year and then every 1 year follow-up, and imaging was performed every year with mammogram and ultrasonography. Benign phyllodes tumor patients had a median follow-up time of 68.8 months, borderline 86.1 and malignant 70.6 months ([Table 1](#T0001){ref-type="table"}). Out of 181 cases, 9 cases experienced recurrence: 5 benign phyllodes tumor (local recurrence), 1 borderline and 3 malignant (1 case developed pulmonary metastasis). All recurrence was no upgrade rate found. We found that younger age (≤45 yrs) malignant phyllodes tumor and size of the tumor are the highest risk factors for recurrence after operation ([Table 3](#T0003){ref-type="table"}).

The standard treatment of phyllodes is surgical excision with a margin of at least 1 cm to decrease the rate of recurrence.[@CIT0007]--[@CIT0009] In our patients (all grades of phyllodes tumor), a surgical margin of less than 1 cm did not affect recurrence ([Figure 2](#F0002){ref-type="fig"}, *P*-value=0.39). Subgroup analysis was done by phyllodes grade. There was statistical difference in margin of malignant phyllodes tumor to risk for recurrence (*P*-value=0.022) but not affected in benign and borderline phyllodes tumor (*P*-value=0.334 and 0.668, respectively) ([Figure 3](#F0003){ref-type="fig"}). Figure 2Kaplan--Meier curve showed recurrence by surgical margin of all phyllodes tumors (*P*=0.737).Figure 3Kaplan--Meier curve showed recurrence of phyllodes tumor in each classification between free surgical margin and positive margin (*P*-value).

Discussion {#S0005}
==========

Phyllodes tumors are rare fibroepithelial tumors found in about 0.5% of the breast neoplasm incidence.[@CIT0010] The most common age range for development is 45--49 years old which is older than the fibroadenoma highest risk group by 20 years;[@CIT0011] however, in our patient sample, the average age is 35 years old. Clinical presentation is usually a painless rapid growing mass. Images from mammography and ultrasonography should indicate suspect phyllodes tumor if the tumor is a well-circumscribed oval or lobulated mass with rounded borders.[@CIT0004] Most tumors, 112 cases, in our hospital records, involved a lobulated shaped mass. Most of the imaging characteristic is difficult to distinguish fibroadenoma from phyllodes tumor.[@CIT0012],[@CIT0013] The size of the tumor should be considered. The average size of fibroadenoma was 2 cm while phyllodes tumor was 4--7 cm.[@CIT0004],[@CIT0010],[@CIT0014],[@CIT0015] In our study, the average size of phyllodes tumor is centimeters and more increase in size followed by the type of phyllodes (3.5 cm in benign, 6.6 cm in borderline and 8.2 cm in malignant). Surgical management to remove the tumor is the mainstay for treatment of all classifications of phyllodes tumors with the aim of achieving a negative margin of at least 1 cm to reduce local recurrence.[@CIT0007],[@CIT0008],[@CIT0010],[@CIT0016] If the surgical margin does not reach 1 cm, further management is different in each classification of phyllodes. Benign phyllodes tumors should be watched carefully because positive margin in benign did not relate to local recurrence.[@CIT0017] But in cases of borderline and malignant phyllodes tumors, a re-excision or mastectomy to achieve an adequate margin should be carried out.[@CIT0004],[@CIT0018] In our study, we found that borderline phyllodes tumors did not differ recurrence rate between negative and positive margin (*P*-value=0.669) while the malignant phyllodes tumors were to recur more frequently in cases of an inadequate margin significantly (*P*-value=0.022) ([Figure 3](#F0003){ref-type="fig"}). This result was similar to Lu et al.[@CIT0018] Adjuvant radiotherapy (RT) in cases of phyllodes is still controversial. National Comprehensive Cancer Network (NCCN) and the other studies suggest the use of RT in recurrent cases of malignant phyllodes.[@CIT0019] Some authors suggest adjuvant RT to decrease the possibility of local recurrence in both borderline and malignant phyllodes tumor patients who are treated with breast-conserving surgery.[@CIT0020] However, RT did not affect overall survival (OS) and disease-free survival (DFS).[@CIT0020],[@CIT0021] In our institution, we consider the use of RT in the case of malignant phyllodes tumor patients undergoing surgical management with wide excision.

In conclusion from our study, the surgical margin did not significantly affect the risk of local recurrence in all subtypes and resulted in a good outcome in benign and borderline cases. However, malignant phyllodes patients are at a more increased risk of recurrence than other types, so a wide margin should always be considered in this type.
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[^1]: **Abbreviations:** UOQ, upper outer quadrant; UIQ, upper inner quadrant; LIQ, lower inner quadrant; LOQ, lower outer quadrant.
